Zevra Therapeutics Inc. (ZVRA) financials · rev $106.5M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Zevra Therapeutics Inc. (ZVRA) rev $106.5M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $106.5M | $23.6M |
| Operating Income | -$62.9M | -$87.0M |
| Net Income | $83.2M | -$105.5M |
| EPS (Diluted) | $1.35 | -$2.28 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $284.7M | $178.1M |
| Current Assets | $223.0M | $86.0M |
| Cash & Equivalents | $62.4M | $33.8M |
| Inventory | $1.74M | $1.97M |
| PP&E | $489.0K | $356.0K |
| Total Liabilities | $130.1M | $138.5M |
| Current Liabilities | $39.3M | $34.1M |
| Long-term Debt | $61.9M | $59.5M |
| Total Debt | $61.9M† | $59.5M† |
| Shareholders' Equity | $154.7M | $39.7M |
| Retained Earnings | -$422.1M | -$505.3M |
† Total Debt: Derived from long-term debt only (no total or short-term debt stored).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$1.60M | -$69.7M |
| CapEx | $835.0K | N/A |
| Investing Cash Flow | $18.1M | -$22.2M |
| Financing Cash Flow | $12.1M | $82.1M |
| Net Change in Cash | $28.6M | -$9.26M |
| Free Cash Flow | -$2.43M | -$69.7M |
FAQ
What is ZVRA P/E and revenue?
Zevra Therapeutics Inc. (ZVRA) rev $106.5M.
What is ZVRA revenue?
Zevra Therapeutics Inc. last cached revenue is $106.5M (FY2025).
Is ZVRA profitable?
Zevra Therapeutics Inc. last cached net income is $83.2M (FY2025).
What are ZVRA total assets?
Zevra Therapeutics Inc. last cached total assets are $284.7M (FY2025).
What is ZVRA free cash flow?
Zevra Therapeutics Inc. last cached free cash flow is -$2.43M (FY2025).
Not investment advice. Cached statements, not a live tape.